FDA Panel Backs Accelerated Approval for Biogen's ALS Drug

Argentina Noticias Noticias

FDA Panel Backs Accelerated Approval for Biogen's ALS Drug
Argentina Últimas Noticias,Argentina Titulares
  • 📰 Medscape
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 55%

FDA panel backs accelerated approval for Biogen's ALS drug. MedTwitter FDA ALS

- A panel of advisers to the U.S. drug regulator voted that data on Biogen Inc's experimental treatment for ALS, also known as Lou Gehrig's disease, shows that the drug could work, potentially paving the way for an accelerated approval.

The U.S. Food and Drug Administration panel's vote was as expected and supportive of the drug's accelerated approval, said SVB Securities analyst Marc Goodman.In a second vote, the panel said there was not enough convincing evidence to show the effectiveness of tofersen for the disease, reducing the chances of a full approval for now.

If tofersen is approved under the agency's accelerated approval pathway, a confirmatory trial will need to show the drug provides a clinical benefit for it to remain in the market.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Medscape /  🏆 386. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA advisors reject Biogen's ALS drug for rare and aggressive form of the diseaseFDA advisors reject Biogen's ALS drug for rare and aggressive form of the diseaseFDA advisors voted against Biogen's investigational ALS drug, which could become the first to target a genetic cause of the disease.
Leer más »

FDA advisers give partial backing to ALS drugFDA advisers give partial backing to ALS drugFDA advisers on Wednesday signaled openness to expediting an experimental drug from Biogen that targets a rare form of ALS.
Leer más »

FDA advisors vote against effectiveness of Biogen's ALS drug for rare and aggressive form of the diseaseFDA advisors vote against effectiveness of Biogen's ALS drug for rare and aggressive form of the diseaseFDA advisors voted against the effectiveness of Biogen's investigational ALS drug, which could become the first to target a genetic cause of the disease.
Leer más »

Trump grand jury live updates: Panel scheduled to resume work on porn star payoff probeTrump grand jury live updates: Panel scheduled to resume work on porn star payoff probeFormer President Donald Trump expects to be arrested over a hush money payoff to porn star Stormy Daniels. Follow live updates on the grand jury probe of him.
Leer más »

House Intel panel launches bipartisan effort to renew surveillance programHouse Intel panel launches bipartisan effort to renew surveillance programA bipartisan group of lawmakers launch an effort to save a secretive government spy tool that faces an uphill battle for reauthorization amid increased skepticism of the 9/11-era surveillance program.
Leer más »

Trump Grand Jury Live Updates: Panel Gets Day Off, Pushing Possible Indictment DateTrump Grand Jury Live Updates: Panel Gets Day Off, Pushing Possible Indictment DateFormer President Donald Trump expects to be arrested over a hush money payoff to porn star Stormy Daniels. Follow live updates on the grand jury probe of him.
Leer más »



Render Time: 2025-04-24 16:03:46